首页 >
法规速递
-
Page: Maximum residue limits (MRLs): Questions and answers-2026/4/8
2026-04-09查看详情 > -
国家药监局关于修订胸腺肽注射剂说明书的公告（2023年第3号）-2023/01/09
2023-01-09查看详情 > -
关于公开征求《糖尿病视网膜病变相关中药新药临床研发技术指导原则（征求意见稿）》意见的通知-2023/7/17
2023-07-21查看详情 > -
Page: Clinical evaluation of medicinal products intended for treatment of hepatitis B - Scientific guideline-2024/1/26
2024-02-05查看详情 > -
Document: Committee on Herbal Medicinal Products (HMPC): Work Plan 2025-2025/1/30
2025-02-05查看详情 > -
Page: Website outages and upgrades-2025/3/7
2025-03-10查看详情 > -
Document: Minutes of the PRAC meeting 28-31 October 2024-2025/4/9
2025-04-11查看详情 > -
国家药监局药审中心关于发布《阿尔茨海默病药物临床试验技术指导原则（试行）》的通告（2025年第19号）-2025/5/22
2025-05-23查看详情 > -
Document: Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)-2025/6/27
2025-06-30查看详情 > -
Page: Paclitaxel product-specific bioequivalence guidance-2025/7/30
2025-07-31查看详情 >
